TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | -1 | 3 | -4 | 54 | 47 | -34 | 11 |
| S | %wins | 100 | 0 | 50 | 0 | 0 | 100 | 42 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/5/09 17:01 | 6/3/09 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | H.I.G. Oncogenex, Inc. | FL | T | S | -2,079 | 20.79 | 9 | -100 | -15 | 546 | D | -77 | 321 | 999 | 537 | 438 | 229 | 45 | 33 | -1 | 3 | -14 | 48 | 33 | -43 | |
5/28/09 11:02 | 5/22/09 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | H.I.G. Oncogenex, Inc. | FL | T | S | -1,892 | 21.41 | 5 | -88 | -12 | 646 | D | -81 | 237 | 733 | 449 | 371 | 198 | 144 | 20 | 0 | 3 | 6 | 59 | 60 | -25 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |